Transport of L-arginine and the nitric oxide inhibitor N-G-monomethyl-L-arginine in human erythrocytes in chronic renal failure

被引:37
|
作者
Ribeiro, ACM
Hanssen, H
Kiessling, K
Roberts, NB
Mann, GE
Ellory, JC
机构
[1] ROYAL LIVERPOOL HOSP, DEPT CLIN CHEM, LIVERPOOL L7 8XP, MERSEYSIDE, ENGLAND
[2] UNIV LONDON KINGS COLL, DIV BIOMED SCI, VASC BIOL RES CTR, LONDON W8 7AH, ENGLAND
关键词
arginine transport; dialysis; erythrocytes; N-G-monomethyl-L-arginine transport; uraemia;
D O I
10.1042/cs0930057
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1. Transport of L-arginine and the nitric oxide synthase inhibitors N-G-monomethyl-L-arginine and N-G-nitro-L-arginine was investigated in human erythrocytes from healthy donors and uraemic patients on haemodialysis. 2. Although K-m values for total L-arginine influx were not significantly different in erythrocytes freshly isolated from controls or uraemic patients, uraemia was associated with an increase in the V-max for transport (826 compared with 1176 mu mol h(-1) l(-1) of cells) which was reduced to control values after dialysis. 3. Saturable influx of L-arginine was mediated by the classical cationic amino acid transport system y+ and system y+L, known to transport cationic and neutral amino acids with higher affinity. 4. Under zero-trans conditions, the V-max for L-arginine transport via system y+ increased from 271 to 700 mu mol h(-1) l(-1) of cells in uraemia, while K-m values increased from 44 to 94 mu mol/l. Dialysis had no significant effect on the kinetic parameters altered by uraemia. 5. Under zero-trans conditions, and with system y+ inhibited by N-ethylmaleimide (0.2 mmol/l), transport of L-arginine via system y+L was unaffected by uraemia, 6. Saturable influx of N-G-monomethyl-L-arginine was also mediated by systems y+ (K-m = 56 mu mol/l, V-max = 353 mu mol h(-1) l(-1) of cells) and y+L (K-m = 17 mu mol/l, V-max = 51.3 mu mol h(-1) l(-1) of cells) and, as with L-arginine, uraemia increased the transport capacity for N-G-monomethyl-L-arginine. 7. Influx of the neutral nitric oxide synthase inhibitor N-G-nitro-L-arginine was not readily saturable, 8. Intracellular concentrations of L-arginine and N-G-monomethyl-L-arginine were significantly increased in erythrocytes from uraemic patients when compared with controls, consistent with an increased transport capacity for L-arginine and N-G-monomethyl-L-arginine. 9. The present study provides evidence that system y+ mediates the increased transport of L-arginine and N-G-monomethyl-L-arginine in human erythrocytes from patients with chronic renal failure, Our findings may have implications for the activity of the L-arginine-nitric oxide signalling pathway in vascular endothelial and smooth-muscle cells in uraemia.
引用
收藏
页码:57 / 64
页数:8
相关论文
共 50 条
  • [21] Nitric oxide/L-arginine in uremia
    Aiello, S
    Noris, M
    Remuzzi, G
    MINERAL AND ELECTROLYTE METABOLISM, 1999, 25 (4-6) : 384 - 390
  • [22] NITRIC-OXIDE SYNTHESIS AND THE EFFECT OF AMINOGUANIDINE AND N-G-MONOMETHYL-L-ARGININE ON THE ONSET OF DIABETES IN THE SPONTANEOUSLY DIABETIC BB RAT
    WU, GY
    DIABETES, 1995, 44 (03) : 360 - 364
  • [23] Effects of homocysteine on L-arginine transport and nitric oxide formation in human platelets
    Leoncini, G
    Pascale, R
    Signorello, MG
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (08) : 713 - 719
  • [24] L-Arginine Transport and Nitric Oxide Synthesis in Human Endothelial Progenitor Cells
    Diaz-Perez, Francisca
    Radojkovic, Claudia
    Aguilera, Valeria
    Veas, Carlos
    Gonzalez, Marcelo
    Lamperti, Liliana
    Escudero, Carlos
    Aguayo, Claudio
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 60 (05) : 439 - 449
  • [25] THE EFFECT OF EXPERIMENTAL CHRONIC-RENAL-FAILURE (CRF) ON L-ARGININE - NITRIC-OXIDE (NO) PATHWAY
    ZHOU, XJ
    VAZIRI, ND
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 636 - 636
  • [26] L-arginine-induced growth hormone secretion is not influenced by co-infusion of the nitric oxide synthase inhibitor N-monomethyl L-arginine in healthy men
    Fisker, S
    Nielsen, S
    Ebdrup, L
    Bech, JN
    Christiansen, JS
    Pedersen, EB
    Jorgensen, JOL
    GROWTH HORMONE & IGF RESEARCH, 1999, 9 (01) : 69 - 73
  • [27] Thermodynamic analysis of L-arginine and Nω-hydroxyl-L-arginine binding to nitric oxide synthase
    Zakariassen, Henrik
    Cederkvist, F. Henning
    Harbitz, Espen
    Shimizu, Toru
    Lange, Reinhard
    Mayer, Bernd
    Gorren, Antonius C. F.
    Andersson, K. Kristoffer
    Sorlie, Morten
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2008, 1784 (05): : 806 - 810
  • [28] L-ARGININE AND ARGININE ANALOGS IN PROGRESSIVE RENAL-FAILURE
    SANDERS, PW
    BLOOD PURIFICATION, 1995, 13 (3-4) : 219 - 227
  • [29] THE L-ARGININE - NITRIC-OXIDE PATHWAY
    MONCADA, S
    HIGGS, EA
    HODSON, HF
    KNOWLES, RG
    LOPEZJARAMILLO, P
    MCCALL, T
    PALMER, RMJ
    RADOMSKI, MW
    REES, DD
    SCHULZ, R
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 : S1 - S9
  • [30] L-arginine, tetrahydrobiopterin, nitric oxide and diabetes
    Hoang, Hai H.
    Padgham, Samuel V.
    Meininger, Cynthia J.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2013, 16 (01): : 76 - 82